{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:41:06Z","timestamp":1761748866254,"version":"build-2065373602"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Agricultural and Social Development Research Guide Project of Hangzhou","award":["20241029Y029"],"award-info":[{"award-number":["20241029Y029"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,5]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Extracorporeal membrane oxygenation (ECMO) is a life-support technology for refractory cardiac arrest, but the massive blood transfusions required during treatment significantly increase the risk of transfusion-related infections. Hepatitis E virus (HEV) \u2013 traditionally linked to fecal-oral transmission \u2013 is increasingly recognized as a transfusion-transmitted pathogen, especially in emergency settings where urgent blood product infusion is common and routine HEV screening in blood banks is often lacking. However, nursing strategies for managing acute HEV infection after ECMO remain poorly defined, highlighting the need to address this clinical gap.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 35-year-old female nurse developed sudden cardiac arrest due to idiopathic ventricular fibrillation and underwent ECMO. Post-ECMO, she received red blood cells and plasma transfusions. On postoperative day 15, she had worsening liver function (alanine aminotransferase 938 U\/L, total bilirubin 69.3 \u03bcmol\/L) and abnormal coagulation function (prothrombin time [PT] 14.5 seconds), along with intermittent low-grade fever (37.3\u201338.0\u00b0C); subsequent jaundice of the skin, sclera, and urine developed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Next-generation sequencing confirmed acute HEV infection. The diagnosis was further supported by typical liver function abnormalities (marked elevation of transaminases and bilirubin), abnormal coagulation (PT 14.5 seconds), and clinical manifestations of HEV infection (fever, jaundice), with no evidence of other etiologies (e.g., viral hepatitis A\/B\/C, drug-induced liver injury).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>\n                      Comprehensive nursing and clinical interventions were implemented. Daily monitoring: liver function (alanine aminotransferase, aspartate aminotransferase, bilirubin), coagulation status (with focus on PT, e.g., baseline PT 14.5 seconds), and jaundice-related symptoms (skin\/sclera color, pruritus, urine color); gastrointestinal management:\n                      <jats:italic toggle=\"yes\">Bacillus licheniformis<\/jats:italic>\n                      (0.5\u2009g twice daily) to regulate intestinal flora, and lactulose (15\u2009mL twice daily) to promote bowel movement, maintaining gut\u2013liver axis balance; personalized nutritional support: Collaboration with the nutrition department to provide a low-fat semi-liquid diet (1500\u20131600 kcal\/d, 75\u201380\u2009g branched-chain amino acid-rich protein, and adequate vitamins\/minerals); and cardiac follow-up: planning and implementation of implantable cardioverter defibrillator (ICD) implantation on postoperative day 50 (after resolution of liver injury and stabilization of coagulation function).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>After 49 days of hospitalization, the patient\u2019s liver function normalized (total bilirubin within normal range, albumin increased from 31.3 to 35.1\u2009g\/L), coagulation function (PT) returned to normal, and jaundice resolved. She successfully underwent ICD implantation on postoperative day 50. A 3-month follow-up showed no chronic liver damage, and serum HEV-IgM turned negative at 6 months; no malignant arrhythmias or ICD discharges were recorded during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case emphasizes 3 key lessons: Firstly, for patients receiving ECMO and blood transfusions, close monitoring of liver function, coagulation indicators (e.g., PT), and clinical signs of HEV infection (fever, jaundice) is critical for early diagnosis; secondly, multimodal interventions \u2013 combining targeted monitoring (including coagulation tracking), gut\u2013liver axis regulation, and personalized nutrition \u2013 are effective for managing acute HEV infection post-ECMO; and thirdly, timing of ICD implantation (e.g., postoperative day 50, after liver and coagulation stabilization) and collaboration between nursing teams, nutrition departments, and cardiac specialists ensure holistic care, supporting both liver recovery and long-term cardiac safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000044325","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T18:02:21Z","timestamp":1757354541000},"page":"e44325","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["From crisis to recovery: A case report on nursing strategies for hepatitis E post-cardiac arrest"],"prefix":"10.1097","volume":"104","author":[{"given":"Rong","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Hangzhou Third People\u2019s Hospital, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjun","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hangzhou Third People\u2019s Hospital, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0760-7876","authenticated-orcid":false,"given":"Lili","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hangzhou Third People\u2019s Hospital, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hangzhou Third People\u2019s Hospital, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenli","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hangzhou Third People\u2019s Hospital, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Zheng","sequence":"additional","affiliation":[{"name":"Nutrition Department, Hangzhou Third People\u2019s Hospital, Hangzhou, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20251029","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"R2-20251029","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.122.062949","article-title":"Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: results of the ECMO-CS randomized clinical trial.","volume":"147","author":"Ostadal","year":"2023","journal-title":"Circulation"},{"key":"R3-20251029","doi-asserted-by":"crossref","first-page":"1800386","DOI":"10.2807\/1560-7917.ES.2019.24.10.1800386","article-title":"Hepatitis E virus in blood donors in England, 2016 to 2017: from selective to universal screening.","volume":"24","author":"Harvala","year":"2019","journal-title":"Euro Surveill"},{"key":"R4-20251029","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/2772270817666230112123221","article-title":"Hepatitis E virus and zoonosis: recent advances and therapeutic implications.","volume":"17","author":"Hon","year":"2023","journal-title":"Recent Adv Inflamm Allergy Drug Discov"},{"key":"R5-20251029","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/pathogens13121058","article-title":"HEV infection in beta-thalassemia patients.","volume":"13","author":"Papageorgiou","year":"2024","journal-title":"Pathogens"},{"key":"R6-20251029","first-page":"1557577941","article-title":"Reversible fulminant hepatitis secondary to cocaine in the setting of \u03b2-blocker use.","volume":"8","author":"Sharma","year":"2020","journal-title":"J Investig Med High Impact Case Rep"},{"key":"R7-20251029","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/CNQ.0000000000000409","article-title":"Acute liver failure.","volume":"45","author":"Ledgerwood","year":"2022","journal-title":"Crit Care Nurs Q"},{"key":"R8-20251029","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3201\/eid2503.181563","article-title":"Donor-derived genotype 4 hepatitis E virus infection, Hong Kong, China, 2018.","volume":"25","author":"Sridhar","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"R9-20251029","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.3390\/foods12163074","article-title":"Thyme (thymus quinquecostatus celak) polyphenol-rich extract (TPE) alleviates HFD-induced liver injury in mice by inactivating the TLR4\/NF-\u03baB signaling pathway through the gut-liver axis.","volume":"12","author":"Sheng","year":"2023","journal-title":"Foods"},{"key":"R10-20251029","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.3390\/nu15173722","article-title":"Polysaccharides: the potential prebiotics for metabolic associated fatty liver disease (MAFLD).","volume":"15","author":"Guo","year":"2023","journal-title":"Nutrients"},{"key":"R11-20251029","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1007\/s00394-021-02553-9","article-title":"Broccoli microgreens juice reduces body weight by enhancing insulin sensitivity and modulating gut microbiota in high-fat diet-induced C57BL\/6J obese mice.","volume":"60","author":"Li","year":"2021","journal-title":"Eur J Nutr"},{"key":"R12-20251029","doi-asserted-by":"crossref","first-page":"155816","DOI":"10.1016\/j.phymed.2024.155816","article-title":"Beneficial effects of dendrobium officinale national herbal drink on metabolic immune crosstalk via regulate SCFAs-Th17\/Treg.","volume":"132","author":"Dong","year":"2024","journal-title":"Phytomedicine"},{"key":"R13-20251029","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1021\/acs.jafc.0c06346","article-title":"Lactobacillus plantarum KLDS1.0344 and lactobacillus acidophilus KLDS1.0901 mixture prevents chronic alcoholic liver injury in mice by protecting the intestinal barrier and regulating gut microbiota and liver-related pathways.","volume":"69","author":"Li","year":"2021","journal-title":"J Agric Food Chem"},{"key":"R14-20251029","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy.","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"R15-20251029","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.24976\/Discov.Med.202436189.181","article-title":"Gut-liver axis: modulating the gut microbiota and its metabolic products as a potential therapeutic strategy for the treatment of hepatic ischemia-reperfusion injury.","volume":"36","author":"Wang","year":"2024","journal-title":"Discov Med"},{"key":"R16-20251029","doi-asserted-by":"crossref","first-page":"630841","DOI":"10.3389\/fmicb.2021.630841","article-title":"Preventive effects of bacillus licheniformis on heat stroke in rats by sustaining intestinal barrier function and modulating gut microbiota.","volume":"12","author":"Li","year":"2021","journal-title":"Front Microbiol"},{"key":"R17-20251029","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jhep.2018.03.005","article-title":"EASL clinical practice guidelines on hepatitis E virus infection.","volume":"68","author":"Dalton","year":"2018","journal-title":"J Hepatol"},{"key":"R18-20251029","first-page":"412","article-title":"Alcoholic hepatitis: diagnosis and management.","volume":"105","author":"Keating","year":"2022","journal-title":"Am Fam Physician"},{"key":"R19-20251029","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40337-025-01209-x","article-title":"Harnessing precision nutrition to individualize weight restoration in anorexia nervosa.","volume":"13","author":"Rodriguez","year":"2025","journal-title":"J Eat Disord"},{"key":"R20-20251029","doi-asserted-by":"crossref","first-page":"20241023","DOI":"10.1515\/med-2024-1023","article-title":"Effectiveness of nutritional support for clinical outcomes in gastric cancer patients: a meta-analysis of randomized controlled trials.","volume":"19","author":"Zhang","year":"2024","journal-title":"Open Med (Wars)"},{"key":"R21-20251029","doi-asserted-by":"crossref","first-page":"147","DOI":"10.35946\/arcr.v38.2.01","article-title":"Alcoholic liver disease: pathogenesis and current management.","volume":"38","author":"Osna","year":"2017","journal-title":"Alcohol Res"},{"key":"R22-20251029","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s12672-024-01598-6","article-title":"Enhancing CD4+\/CD8+ T cell ratio and accelerating recovery in HNSCC patients through immunonutrition intervention.","volume":"15","author":"Lin","year":"2024","journal-title":"Discov Oncol"},{"key":"R23-20251029","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12879-019-4742-4","article-title":"Gaps between current clinical practice and evidence-based guidelines for treatment and care of older patients with community acquired pneumonia: a descriptive cross-sectional study.","volume":"20","author":"Eekholm","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R24-20251029","doi-asserted-by":"crossref","first-page":"e0263267","DOI":"10.1371\/journal.pone.0263267","article-title":"Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: a brief scoping review.","volume":"17","author":"Efendi","year":"2022","journal-title":"PLoS One"},{"key":"R25-20251029","doi-asserted-by":"crossref","first-page":"48","DOI":"10.18087\/cardio.2025.2.n2764","article-title":"Individualized nutritional support improves cardiac function and nutritional status of elderly heart failure patients.","volume":"65","author":"Chen","year":"2025","journal-title":"Kardiologiia"},{"key":"R26-20251029","first-page":"e10628","article-title":"Acute hepatitis E: a rare cause of acute liver failure in a patient with acute myeloid leukemia.","volume":"12","author":"Field","year":"2020","journal-title":"Cureus"},{"key":"R27-20251029","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tmrv.2019.06.001","article-title":"Transfusion-transmitted hepatitis E virus infection in France.","volume":"33","author":"Gallian","year":"2019","journal-title":"Transfus Med Rev"},{"key":"R28-20251029","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.tracli.2017.06.012","article-title":"HEV and transfusion-recipient risk.","volume":"24","author":"Izopet","year":"2017","journal-title":"Transfus Clin Biol"},{"key":"R29-20251029","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-0033-1338115","article-title":"Hepatitis E virus infection in immunosuppressed patients: natural history and therapy.","volume":"33","author":"Kamar","year":"2013","journal-title":"Semin Liver Dis"},{"key":"R30-20251029","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jhep.2022.05.019","article-title":"Mechanisms of CD8+ T-cell failure in chronic hepatitis E virus infection.","volume":"77","author":"Kemming","year":"2022","journal-title":"J Hepatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:02:36Z","timestamp":1761746556000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":30,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044325","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"assertion":[{"value":"2025-05-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}